Research Award Activity
FY 2021
| Title | Sponsor | Award |
|---|---|---|
| Peer Review of PCORI's Funded Research | Oregon Health and Science University | $45,757 |
| Intervention to Increase Naloxone Engagement and Distribution in Community Pharmacies: A Four-State Randomized Trial | Boston University | $16,446 |
| Biosynthetic studies and development of ribomimetic-based anti-infectives | National Institutes of Health | $357,955 |
| EpiCenter - EPIdemiology of opioid prescribing in community health CENTERs | Oregon Health and Science University | $36,824 |
| Oregon Clinical and Translational Research Institute KL2 Program | Oregon Health and Science University | $35,165 |
| The Chemical Ecology and Group Dynamics of Modern Microbialite Communities | Gordon and Betty Moore Foundation | $299,487 |
| Implementation, Outcomes, and Cost of a Novel Medicaid Policy to Reduce Opioids for Back Pain | Oregon Health and Science University | $89,636 |
| Nanoparticles based mRNA delivery for treatment of cystic fibrosis | National Institutes of Health | $658,627 |
| Discovery and Biological Signatures of Microbiome-Derived Xanthohumol Metabolites and their Role in Ameliorating Inflammatory Bowel Disease | National Institutes of Health | $960,276 |
| Reducing Overdose After Release from Incarceration (ROAR) | Oregon Health and Science University | $92,497 |
| Improving access to care through pharmacist prescription of hormonal contraception | Oregon Health and Science University | $14000 |
| Optimizing Antibiotic Prescribing on Discharge to Long-term Care Facilities | Agency for Healthcare Research and Quality | $547,351 |
| Modulation of Protein Biogenesis and Secretion by Natural Product Translocon Ligands | National Institutes of Health | $388,638 |
| Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia | National Institutes of Health | $446,372 |
| Validation of preclinical assays with clinical data to evaluate the safety of estrogenic botanical dietary supplements | National Institutes of Health | $41,443 |
| Research Training in Natural Product Complementary and Integrative Health | National Institutes of Health | $248,169 |
| Intravascular Delivery of Nanoclusters for Treatment of Deep-Seated Cancers with Magnetic Hyperthermia | National Institutes of Health | $614,464 |
| A nanoparticle-based approach for surgical imaging and intraoperative treatment of endometriosis | Oregon Health and Science University | $103,023 |
| Near Infrared Nerve-specific Fluorophores for Clinical Fluorescence Guided Surgery | Oregon Health and Science University | $12,632 |
| Novel Materials for Gene Delivery to treat CF | Cystic Fibrosis Foundation | $267,433 |
| Overcoming gene delivery barriers to the back of the eye | National Institutes of Health | $238,145 |
| Developing a novel antibiogram tool to improve empiric antibiotic prescribing in nursing homes | University of Wisconsin | $44,735 |
| Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) study | Oregon Health and Science University | $30,420 |
| Intervention to Increase Naloxone Engagement and Distribution in Community Pharmacies: A Four-State Randomized Trial | Brandeis University | $133,930 |
| Metabolic response to traditional diets in Alaska Native people | Oregon Health and Science University | $74,375 |
| Prescription Drug Monitoring Program Integration in the Electronic Health Record | Agency for Healthcare Research and Quality | $140,846 |
| ApoE Isoform-Dependent Changes in Brain Bioenergetics Post-Menopause in Response to Xanthohumol | Collins Medical Trust | $30,000 |
| IIR 17-039 Improving Veteran Health by Increasing Dental Stewardship of Antibiotics and Opioids | Oregon Dept. of Veterans' Affairs | $19,373 |
| Collaborative Research: CompCog:Psychological, computational, and neural adequacy in a deep learning model of human speech recognition | National Science Foundation | $178,934 |
| Small Molecule screen for inhibition of SARS-CoV-2 | ReSeptr Therapeutics, LLC | $21,650 |
| Dual anti-CD47 and Duramycin Functionalized Carriers for Radio-enhanced Drug Delivery | PhRMA Foundation | $25,000 |
| Flip the Pharmacy (FtP) PracNce TransformaNon Team (PTT) | GPP Solutions, LLC | $6,250 |
| Lipid Nanoparticle Delivery of Saliogase EDIT Technology | SalioGen Therapeutics | $99,178 |
| Nanoparticle mediated delivery of modified CFTR mRNA for treatment of cystic fibrosis | Cystic Fibrosis Foundation | $63,350 |
| Microbiota, Tertiary Lymphoid Structures and Chronic Inflammation in the Human Gut | University of Massachusetts | $111,375 |
| Understanding the impact of radiation on endocytosis of small molecule therapies and their nanoformulations | American Foundation for Pharmaceutical Education | $5,000 |
| Role of Non-calcemic vitamin D-hydroxyderivatives as preventive agents in melanoma | Oregon Health and Science University | $50,000 |
| New technologies for inhalable nanoparticles | Rare Air Health, LLC | $31,733 |
| Prepare CPD100Li formulation | Cascade ProDrug Inc | $92,152 |
| Lipid nanoparticles for gene editing | Beam Therapeutics | $390,932 |
FY 2022
| Agency | Type | Grant Code | Award |
|---|---|---|---|
| Health and Environmental Sciences Institute (HESI) | Cooperative Agreement | J25520 | $9,200 |
| Circ Bio Inc. (CBIN) | Contract | VC3070 | $370,400 |
| CTI Biopharma (CTIB) | Contract | VC3000 | $39,377 |
| EnterX Biosciences, Inc. (EXBI) | Contract | VC2960 | $266,493 |
| Liphatech (LXXX) | Contract | VC3160 | $158,000 |
| Rare Air Health, LLC (RAHL) | Contract | VC2680 | $123,834 |
| ReSeptr Therapeutics, LLC (RSTL) | Contract | VC2480 | $43,300 |
| American Foundation for Pharmaceutical (AFPE) | Grant | F11480 | $5,000 |
| Cystic Fibrosis Foundation (CFFX) | Grant | F10610 | $481 |
| National Institutes of Health (NIH) | Grant | P05380 P05400 P05430 | $5,368,653 |
| Dartmouth-Hitchcock Clinic (DHCX) | Sub Grant | U14880 | $13,719 |
| Henry M Jackson Foundation (HMJF) | Sub Grant | F10630 | $512,336 |
| Inherent Targeting LLC (INTA) | Sub Grant | V09070 | $22,433 |
| Massachusetts General Hospital (MGHX) | Sub Grant | J25670 | $185,625 |
| Oregon Health & Science University (OHSU) | Sub Grant | U15700 | $126,736 |
| University of Massachusetts Medical School (UMMS) | Sub Grant | U15480 | $92,813 |
| Agency for Healthcare Research and Quality (AHRQ) | Grant | P04770 P05310 | $226,825 |
| US Department of Veterans Affairs (DVAX) | Interagency Personnel Agreement | X02290 | $39,823 |
| Brandeis University (BRAN) | Sub Grant | U14370 | $106,582 |
| Oregon Health & Science University (OHSU) | Sub Grant | U13070 U13180 U13260 U14360 U15580 | $286,439 |
| University of Wisconsin - Madison (UWMX) | Sub Grant | U15840 | $44,735 |
| Total: | $8,042,804 |
FY 2023
| Agency | Type | Grant Code | Award |
|---|---|---|---|
| PHR - Pharmacy Practice Operations | Primary PI | |||
| US Department of Veterans Affairs (DVAX) | Contract | X02610 | $25,787 |
| National Institutes of Health (NIH) | Grant | P05520 | $483,221 |
| Brandeis University (BRAN) | Sub Grant | U14370 | $70,087 |
| Oregon Health & Science University (OHSU) | Sub Grant | U13070 U13180 U14360 U15580 U16770 | $275,127 |
| University of Colorado Denver (UCOD) | Sub Grant | U17110 | $15,816 |
| University of Wisconsin - Madison (UWMX) | Sub Grant | U16990 | $61,080 |
| Abt Associates (ABTA) | Sub Contract | V09430 | $445,448 |
| Subtotal: | $1,376,567 | ||
| Agency | Type | Grant Code | Award |
|---|---|---|---|
| PHR - Basic Pharm Sci & Pharmacy Practice Operations | PI Type Not Found - Grant Proposal not found | |||
| Henry M Jackson Foundation (HMJF) | Sub Grant | F10620 | $57,452 |
| University of Wisconsin - Madison (UWMX) | Sub Grant | U15840 | $599 |
| Subtotal: | $58,051 | ||
| PHR - Basic Pharm Sci Operations | Primary PI | Subtotal: | $10,030,750 |
|---|---|---|
| PHR - Pharmacy Practice Operations | Primary PI | Subtotal: | $1,376,567 |
| PHR - Basic Pharm Sci & Pharmacy Practice Operations PI Type Not Found - Grant Proposal not found | Subtotal: | $58,051 |
| Subtotal: | $11,465,368 | |